echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > National Cancer Prevention and Treatment Week: The availability of medicines is further improved, and the burden on patients is greatly reduced

    National Cancer Prevention and Treatment Week: The availability of medicines is further improved, and the burden on patients is greatly reduced

    • Last Update: 2021-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    1.
    China urgently needs to increase awareness of family cancer prevention and control
    1.
    China urgently needs to increase awareness of family cancer prevention and control

    In 2020, 19.
    3 million new cancers occurred globally and nearly 10 million died from cancer.
    Among them, female bioon.
    com/tags/%E4%B9%B3%E8%85%BA%E7%99%8C/">breast cancer surpassed lung cancer as the most common cancer in the world for the first time; lung cancer, bioon.
    com/course_video/gan-ai-de-zhuan-hua-yi-xue-yan-jiu198411.
    html">liver cancer , gastric cancer, breast cancer and colorectal cancer are the top five cancers that cause the most deaths.
    The number of new cancers (nearly 4.
    6 million cases, about 24%) and deaths (3 million, about 30%) in China ranks first in the world.
    bioon.
    com/tags/%E4%B9%B3%E8%85%BA%E7%99%8C/">Breast bioon.
    com/course_video/gan-ai-de-zhuan-hua-yi-xue-yan-jiu198411.
    html">cancer


    Cancer prevention and control and regulation require the participation of every family.
    In recent years, anti-cancer themed movies such as "I'm Not the God of Medicine" and "Send You A Little Red Flower" have brought the dilemma faced by families in the process of fighting cancer into the public eye.
    How to enhance the awareness of family cancer prevention and control and popularize basic knowledge of cancer medication has become a key task for cancer prevention and control.
    From April 15th to 21st, 2021, the 27th National bioon.
    com/course_video/chang-fei-bian-ma-RNA-yu-zhong-liu959063.
    html">Cancer Prevention and Treatment Promotion Week was officially launched with the theme of "Healthy Chinese Health Care-Caring for Life Science and Cancer Prevention".
    bioon.
    com/course_video/chang-fei-bian-ma-RNA-yu-zhong-liu959063.
    html">Tumor


    2.
    Chemotherapy is still the cornerstone of cancer treatment


    "All treatments must be safe first.
    The purpose of drug treatment is to prolong the quality of life of patients and make them live longer and more dignified.
    " For different diseases and different patients, no one treatment can cover the world.
    .


    With the development of basic tumor biology such as molecular typing, targeting and immunotherapy have become a hot spot.
    However, traditional chemotherapy is still the cornerstone of anti- bioon.
    com/course_video/chang-fei-bian-ma-RNA-yu-zhong-liu959063.
    html">tumor therapy.
    How to choose the appropriate immunotherapy drugs and design a combination chemotherapy regimen with superior efficacy and low toxicity has become a major difficulty in the clinical treatment of cancer.
    bioon.
    com/course_video/chang-fei-bian-ma-RNA-yu-zhong-liu959063.
    html">Tumor


    The adverse reactions of chemotherapy drugs have always been the focus of attention of doctors and patients.
    With the continuous improvement of drugs, bioon.
    com/course_info/series_11.
    html">adverse reactions have been significantly improved, and chemotherapy is no longer as scary as before.
    Take paclitaxel liposomes as an example: Compared with traditional paclitaxel, Lipusol uses liposomes as a bioon.
    com/tags/%E8%BD%BD%E4%BD%93/">carrier to avoid toxic and side effects on the human body due to the use of mixed solvents.
    At the same time, because of its unique targeting, the drug has a higher concentration in tumor tissues and lymph nodes, longer action time, better anti- bioon.
    com/course_video/chang-fei-bian-ma-RNA-yu-zhong-liu959063.
    html">tumor effects, and better safety and tolerability.
    bioon.
    com/course_info/series_11.
    html">Adverse Reaction bioon.
    com/tags/%E8%BD%BD%E4%BD%93/">Carrier bioon.
    com/course_video/chang-fei-bian-ma-RNA-yu-zhong-liu959063.
    html">Tumor


    3.
    Paclitaxel liposomes have high safety and wide adaptability


    Paclitaxel liposome has a wide range of indications.
    It has been recommended by major guidelines as the first-line drug for breast cancer and primary lung cancer, and the preferred combination drug for chemotherapy of esophageal cancer.
    The latest research progress in 2020 confirmed the important role of paclitaxel liposomes in the diagnosis and treatment of advanced lung squamous cell carcinoma and ovarian cancer.


    A clinical study of lung squamous cell carcinoma led by Shanghai Pulmonary Hospital, Professor Zhou Caicun and researchers from 35 centers showed that the efficacy of paclitaxel liposome combined with cisplatin in the first-line treatment of advanced lung squamous cell carcinoma is comparable to that of gemcitabine combined with cisplatin in the near and long-term The curative effect is equivalent, the overall survival time of the former is 2.
    1 months longer than that of the latter (14.
    6m vs 12.
    5m), and the safety is significantly higher than the latter.
    Compared with the albumin paclitaxel and gemcitabine treatment plan, the administration is more convenient, once every cycle (21 days), the medication is more convenient and the compliance is higher.


    A study published by the Department of Gynecology, Xiangya Hospital of Central South University in the International Journal of Gynecology & Obstetrics found that paclitaxel liposomes have lower side effects and higher safety in the treatment of ovarian cancer, and the incidence of peripheral neuropathy (CIPN) is lower.
    .



    4.
    Improve the availability of medicines and help families fight cancer


    Improving the accessibility of cancer drugs is something that the country and many pharmaceutical companies are committed to achieving.
    In 2016, the "Expenditure and Financial Burden of Common Cancers in China" published by The Lancet magazine showed that the average annual expenditure of Chinese cancer patients is as high as 64,000, which exceeds the average annual family income (56,000), which means that most cancer patients have Need to borrow money to see a doctor, or even give up some treatments.



    In 2020, Lipusol®, the world’s first and only liposomal paclitaxel product approved for sale in China, will be included in the new version of the National Medical Insurance Catalogue for all indications, including non-small cell lung cancer, ovarian cancer and breast cancer.
    Reimbursed by National Medical Insurance.
    The reimbursement ratio of 70%-80% has greatly reduced the financial burden of cancer patients, which means that the accessibility of cancer drugs has been further improved.


    The burden of cancer in China is heavy.
    The family is the most basic unit of society.
    Only by actively participating can we increase the awareness of cancer prevention and control in the whole society, curb the social harm caused by cancer, and reduce the burden of cancer diseases.
    I hereby appeal to the majority of families to actively understand health knowledge, urge family members to change bad habits such as unhealthy diet, smoking, alcoholism, lack of exercise, etc.
    , create a good family environment, maintain a comfortable mood, and guard the first gateway to cancer invasion.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.